Custom oligonucleotide manufacturing from preclinical to commercial scale
Nitto Avecia manufactures oligonucleotides for pharmaceutical innovators, operating a complex manufacturing footprint with SAP S/4HANA, LIMS, and specialized analytical tools (HPLC, Minitab). The hiring mix—weighted heavily toward manufacturing and operations roles—reflects their core constraint: scaling production capacity while managing material supply chains, equipment reliability, and process efficiency. Active projects center on EQMS implementation, process validation, and cost-of-goods reduction, suggesting operational maturity challenges typical of contract manufacturers managing regulatory compliance and multi-tenant production.
Nitto Avecia is a contract manufacturer specializing in oligonucleotide synthesis and development services for pharmaceutical companies. The company serves clients across the preclinical-to-commercial lifecycle, offering custom manufacturing, analytical testing, process validation, and stability services. Based in Milford, MA, with 501–1,000 employees, Nitto Avecia operates a regulated manufacturing environment requiring validation protocols, spare-parts logistics, and inventory control. The business is capital-intensive and project-driven, with tight dependencies on raw material supply, equipment uptime, and process documentation.
SAP S/4HANA for enterprise resource planning, LIMS for lab data management, HPLC for analytical testing, Minitab for statistical analysis, and CMMS for equipment maintenance. Smartsheet and Jira support project governance.
EQMS implementation, oligonucleotide process validation, reducing cost of goods, commercializing new oligo manufacturing technologies, and reducing equipment downtime and material delays.
Other companies in the same industry, closest in size